Showing results (431-440 of 604) with videos related to
Sort By:
Pageof 61
Annals of Surgical Oncology|October 17, 2008
Nipple-sparing mastectomy: critical assessment of 51 procedures and implications for selection criteriaAnna M Voltura, Theodore N Tsangaris, Gedge D Rosson, et al.The American Journal of Cardiology|June 15, 1991
Detection of intracoronary fibrin degradation after coronary balloon angioplastyM E Ring, J J Vecchione, L D Fiore, et al.The American Journal of Cardiology|March 15, 1997
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy TrialG N Levine, A K Jacobs, G P Keeler, et al.Journal of Interventional Cardiology|November 17, 2006
Marked improvements in outcomes of contemporary percutaneous coronary intervention in patients with diabetes mellitusAndrew M Freeman, J Dawn Abbott, Alice K Jacobs, et al.The American Journal of Cardiology|May 10, 2005
Importance of the postdischarge interval in assessing major adverse clinical event rates following percutaneous coronary interventionWarren K Laskey, Faith Selzer, Alice K Jacobs, et al.The American Journal of Cardiology|June 13, 2006
Recent trends in the percutaneous treatment of chronic total coronary occlusionsJ Dawn Abbott, Kevin E Kip, Helen A Vlachos, et al.Coronary Artery Disease|May 26, 2005
Cardiogenic shock: predictors of outcome based on right and left ventricular size and function at presentationLisa A Mendes, Michael H Picard, Lynn A Sleeper, et al.The Annals of Thoracic Surgery|May 13, 1999
Effect of gender on postoperative outcomes and hospital stays after coronary artery bypass graftingG S Aldea, J M Gaudiani, O M Shapira, et al.Muscle & Nerve|January 24, 2025
Ultrasound Evaluation of Upper Limb Sublesional Muscle Morphology in Cervical Spinal Cord InjuryHannah J Ro, Emmanuel Ogalo, Mathew I B Debenham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2016
Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trialN Harbeck, S Iyer, N Turner, et al.Pageof 61